These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 27203739)

  • 1. Radiobiological modeling of two stereotactic body radiotherapy schedules in patients with stage I peripheral non-small cell lung cancer.
    Huang BT; Lin Z; Lin PX; Lu JY; Chen CZ
    Oncotarget; 2016 Jun; 7(26):40746-40755. PubMed ID: 27203739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiobiological modeling analysis of the optimal fraction scheme in patients with peripheral non-small cell lung cancer undergoing stereotactic body radiotherapy.
    Huang BT; Lu JY; Lin PX; Chen JZ; Li DR; Chen CZ
    Sci Rep; 2015 Dec; 5():18010. PubMed ID: 26657569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiobiological impact of dose calculation algorithms on biologically optimized IMRT lung stereotactic body radiation therapy plans.
    Liang X; Penagaricano J; Zheng D; Morrill S; Zhang X; Corry P; Griffin RJ; Han EY; Hardee M; Ratanatharathom V
    Radiat Oncol; 2016 Jan; 11():10. PubMed ID: 26800883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calculating the individualized fraction regime in stereotactic body radiotherapy for non-small cell lung cancer based on uncomplicated tumor control probability function.
    Lu JY; Lin PX; Huang BT
    Radiat Oncol; 2019 Jun; 14(1):111. PubMed ID: 31221159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Voxel-Level BED Corrected Dosimetric and Radiobiological Assessment of 2 Kinds of Hybrid Radiotherapy Planning Methods for Stage III NSCLC.
    Wang H; Huang Y; Chen H; Shao Y; Duan Y; Feng A; Gu H; Ma X; Xu Z; Kong Q; Zhou Y
    Technol Cancer Res Treat; 2022; 21():15330338221107966. PubMed ID: 35731648
    [No Abstract]   [Full Text] [Related]  

  • 6. Non-coplanar VMAT combined with non-uniform dose prescription markedly reduces lung dose in breath-hold lung SBRT.
    Fleckenstein J; Boda-Heggemann J; Siebenlist K; Gudzheva T; Prakofyeva N; Lohr F; Wenz F; Simeonova-Chergou A
    Strahlenther Onkol; 2018 Sep; 194(9):815-823. PubMed ID: 29802434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic ablative radiotherapy for ultra-central lung tumors: prioritize target coverage or organs at risk?
    Murrell DH; Laba JM; Erickson A; Millman B; Palma DA; Louie AV
    Radiat Oncol; 2018 Apr; 13(1):57. PubMed ID: 29606150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integration of radiobiological modeling and indices in comparative plan evaluation: A study comparing VMAT and 3D-CRT in patients with NSCLC.
    Roy S; Badragan I; Ahmed SN; Sia M; Singh J; Bahl G
    Pract Radiat Oncol; 2018; 8(5):e355-e363. PubMed ID: 29703705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetric Comparison of Real-Time MRI-Guided Tri-Cobalt-60 Versus Linear Accelerator-Based Stereotactic Body Radiation Therapy Lung Cancer Plans.
    Wojcieszynski AP; Hill PM; Rosenberg SA; Hullett CR; Labby ZE; Paliwal B; Geurts MW; Bayliss RA; Bayouth JE; Harari PM; Bassetti MF; Baschnagel AM
    Technol Cancer Res Treat; 2017 Jun; 16(3):366-372. PubMed ID: 28168936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosimetric impact of breathing motion in lung stereotactic body radiotherapy treatment using intensity modulated radiotherapy and volumetric modulated arc therapy [corrected].
    Rao M; Wu J; Cao D; Wong T; Mehta V; Shepard D; Ye J
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):e251-6. PubMed ID: 22365622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of FDG-PET to guide dose prescription heterogeneity in stereotactic body radiation therapy for lung cancers with volumetric modulated arc therapy: a feasibility study.
    de Figueiredo BH; Antoine M; Trouette R; Lagarde P; Petit A; Lamare F; Hatt M; Fernandez P
    Radiat Oncol; 2014 Dec; 9():300. PubMed ID: 25534014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applicability of the linear-quadratic formalism for modeling local tumor control probability in high dose per fraction stereotactic body radiotherapy for early stage non-small cell lung cancer.
    Guckenberger M; Klement RJ; Allgäuer M; Appold S; Dieckmann K; Ernst I; Ganswindt U; Holy R; Nestle U; Nevinny-Stickel M; Semrau S; Sterzing F; Wittig A; Andratschke N; Flentje M
    Radiother Oncol; 2013 Oct; 109(1):13-20. PubMed ID: 24183066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic body radiotherapy: volumetric modulated arc therapy versus 3D non-coplanar conformal radiotherapy for the treatment of early stage lung cancer.
    Herbert C; Kwa W; Nakano S; James K; Moiseenko V; Wu J; Schellenberg D; Liu M
    Technol Cancer Res Treat; 2013 Dec; 12(6):511-6. PubMed ID: 23617285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regression models for predicting physical and EQD
    Wang H; Zhou Y; Gan W; Chen H; Huang Y; Duan Y; Feng A; Shao Y; Gu H; Kong Q; Xu Z
    Radiat Oncol; 2021 Jun; 16(1):119. PubMed ID: 34176503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Volumetric-modulated arc therapy for stereotactic body radiotherapy of lung tumors: a comparison with intensity-modulated radiotherapy techniques.
    Holt A; van Vliet-Vroegindeweij C; Mans A; Belderbos JS; Damen EM
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1560-7. PubMed ID: 21300461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetric comparison of two arc-based stereotactic body radiotherapy techniques for early-stage lung cancer.
    Liu H; Ye J; Kim JJ; Deng J; Kaur MS; Chen ZJ
    Med Dosim; 2015; 40(1):76-81. PubMed ID: 25499078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the validity of density overrides for VMAT lung SBRT planning.
    Wiant D; Vanderstraeten C; Maurer J; Pursley J; Terrell J; Sintay BJ
    Med Phys; 2014 Aug; 41(8):081707. PubMed ID: 25086517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A treatment-planning comparison of three beam arrangement strategies for stereotactic body radiation therapy for centrally located lung tumors using volumetric-modulated arc therapy.
    Ishii K; Okada W; Ogino R; Kubo K; Kishimoto S; Nakahara R; Kawamorita R; Ishii Y; Tada T; Nakajima T
    J Radiat Res; 2016 Jun; 57(3):273-9. PubMed ID: 26951076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetric comparison of flattened and unflattened beams for stereotactic ablative radiotherapy of stage I non-small cell lung cancer.
    Hrbacek J; Lang S; Graydon SN; Klöck S; Riesterer O
    Med Phys; 2014 Mar; 41(3):031709. PubMed ID: 24593713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4D VMAT, gated VMAT, and 3D VMAT for stereotactic body radiation therapy in lung.
    Chin E; Loewen SK; Nichol A; Otto K
    Phys Med Biol; 2013 Feb; 58(4):749-70. PubMed ID: 23324560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.